New UK (NICE) guidelines for CVD
Executive summary * The National Institute for Clinical Excellence (NICE) is the organisation in the UK that sets medical guidelines
Read More
Cholesterol
LDL-C & heart disease – definitive proof?
Executive summary * PCSK9s are relatively recent additions to the array of cholesterol lowering drugs. They are delivered by injection
Read More
Finland, diet, cholesterol & heart disease
Executive Summary * This is the second part of the review of the North Karelia study, which claimed that reducing
Read More
The Lipid Energy Model
Executive summary * This week’s note builds on last week’s note about lean mass hyper-responders. This was the term developed
Read More
Lean Mass Hyper-Responders
Executive summary * The term “Lean Mass Hyper-Responder” was developed by Dave Feldman in reference to those with the combination
Read More
Eggs, cholesterol & mortality
Executive Summary * The paper being reviewed this week claimed that dietary cholesterol and egg intake are associated with higher
Read More
Is HDL-cholesterol bad?
Executive summary * This week’s note reviews a paper, which found that very high HDL-cholesterol levels are associated with higher
Read More
Cholesterol & Coffee
Executive summary * This week’s note looks at the association between coffee consumption and total cholesterol. * Coffee contains two
Read More
A new look at statins, LDL-Cholesterol & CVD
Executive summary * Most papers presenting the benefits of statins have been done by the Oxford Cholesterol Treatment Trialists (CTT)
Read More
Inclisiran
Executive summary * The UK National Institute for Health and Care Excellence (guideline setting organisation) has approved a PCSK9 inhibitor
Read More